SCHEMBL6978871

SCHEMBL6978871

CC(C)(C)OC(=O)N1C(=O)CCCCC1CN1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ATM Q13315 2/20 0.41
RECQL P46063 1/20 0.41
PARP1 P09874 1/20 0.35
GLA P06280 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
BCL2 P10415 1/20 0.34
OPRK1 P41145 2/20 0.33
USP30 Q70CQ3 1/20 0.33
BRD4 O60885 1/20 0.33
BRD2 P25440 1/20 0.33
BRD3 Q15059 1/20 0.33
BRDT Q58F21 1/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978486 0.83 USP2 (0.41) USP2SMN1; SMN2ATMRECQLGLA
SCHEMBL9082017 0.82 RAB9A (0.38) OPRK1NPC1CYP1A2CYP3A4CYP2D6
SCHEMBL4719550 0.78 SMN1; SMN2 (0.48) USP2SMN1; SMN2ATMRECQLALDH1A1
SCHEMBL4719547 0.78 SMN1; SMN2 (0.48) USP2SMN1; SMN2ATMRECQLALDH1A1
SCHEMBL6304018 0.78 SMN1; SMN2 (0.48) USP2SMN1; SMN2ATMRECQLALDH1A1
SCHEMBL6972167 0.77 ATM (0.38) ATMPARP1GPR119OPRK1
SCHEMBL6979848 0.76 ATM (0.37) ATMPARP1GPR119ALDH1A1
SCHEMBL6969595 0.75 DDB1 (0.38) ATMPARP1GPR119ALDH1A1
SCHEMBL7005041 0.73 SMN1; SMN2 (0.43) USP2SMN1; SMN2ATMRECQLOPRK1
SCHEMBL7005037 0.73 SMN1; SMN2 (0.43) USP2SMN1; SMN2ATMRECQLOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed